The Journal of Immunology, Vol 155, Issue 9 4497-4503, Copyright © 1995 by American Association of Immunologists

ARTICLES

Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease

LC Pullen, SH Park, SD Miller, MC Dal Canto and BS Kim
Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, IL 60611, USA.

Theiler's murine encephalomyelitis virus (TMEV) induces a demyelinating disease in susceptible strains, which clinically and histopathologically resembles human multiple sclerosis. Since bacterial LPS produced by Gram-negative bacteria is known to potentiate an immune response and trigger resident central nervous system cells to produce various inflammatory cytokines, we examined the ability of LPS to affect resistance to TMEV-induced demyelinating disease (TMEV-IDD). Intraperitoneal injection of LPS, concomitant with intracerebral of genetically resistant C57BL/6 mice with TMEV, resulted in clinical symptoms in approximately 50% of the group. The increase in susceptibility following LPS treatment correlated with the enhanced levels of TMEV-specific delayed-type hypersensitivity and T cell proliferative responses. Similar treatment with LPS, however, did not accelerate the clinical course of susceptible (SJL/J) or intermediately susceptible (C3H) mice. The LPS-treated C57BL/6 mice displayed an increased viral persistence in the central nervous system when compared with nontreated control mice. Intraperitoneal administration of IL-1 beta could mimic the LPS effect in C57BL/6 mice, suggesting that the increase in susceptibility to TMEV-IDD may function via IL-1 produced following LPS stimulation.

This article has been cited by other articles:

				J. Myoung, Y. Y. Bahk, H. S. Kang, M. C. Dal Canto, and B. S. Kim Anticapsid Immunity Level, Not Viral Persistence Level, Correlates with the Progression of Theiler's Virus-Induced Demyelinating Disease in Viral P1-Transgenic Mice J. Virol., June 1, 2008; 82(11): 5606 - 5617. [Abstract] [Full Text] [PDF]

				Y.-H. Jin, M. Mohindru, M. H. Kang, A. C. Fuller, B. Kang, D. Gallo, and B. S. Kim Differential Virus Replication, Cytokine Production, and Antigen-Presenting Function by Microglia from Susceptible and Resistant Mice Infected with Theiler's Virus J. Virol., November 1, 2007; 81(21): 11690 - 11702. [Abstract] [Full Text] [PDF]

				A. C. Fuller, B. Kang, H. K. Kang, H. Yahikozowa, M. C. Dal Canto, and B. S. Kim Gender Bias in Theiler's Virus-Induced Demyelinating Disease Correlates with the Level of Antiviral Immune Responses J. Immunol., September 15, 2005; 175(6): 3955 - 3963. [Abstract] [Full Text] [PDF]

				E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas Theiler's Virus Infection: a Model for Multiple Sclerosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207. [Abstract] [Full Text] [PDF]

				J. P. Palma, D. Kwon, N. A. Clipstone, and B. S. Kim Infection with Theiler's Murine Encephalomyelitis Virus Directly Induces Proinflammatory Cytokines in Primary Astrocytes via NF-{kappa}B Activation: Potential Role for the Initiation of Demyelinating Disease J. Virol., June 1, 2003; 77(11): 6322 - 6331. [Abstract] [Full Text] [PDF]

				B.-S. Kang, M. A. Lyman, and B. S. Kim The Majority of Infiltrating CD8+ T Cells in the Central Nervous System of Susceptible SJL/J Mice Infected with Theiler's Virus Are Virus Specific and Fully Functional J. Virol., June 5, 2002; 76(13): 6577 - 6585. [Abstract] [Full Text] [PDF]

				J. P. Palma, R. L. Yauch, H.-K. Kang, H.-G. Lee, and B. S. Kim Preferential Induction of IL-10 in APC Correlates with a Switch from Th1 to Th2 Response Following Infection with a Low Pathogenic Variant of Theiler's Virus J. Immunol., April 15, 2002; 168(8): 4221 - 4230. [Abstract] [Full Text] [PDF]

				L. A. Doughty, K. B. Nguyen, J. E. Durbin, and C. A. Biron A Role for IFN-{{alpha}}{{beta}} in Virus Infection-Induced Sensitization to Endotoxin J. Immunol., February 15, 2001; 166(4): 2658 - 2664. [Abstract] [Full Text] [PDF]

				K. M. Drescher, P. D. Murray, X. Lin, J. A. Carlino, and M. Rodriguez TGF-{beta}2 Reduces Demyelination, Virus Antigen Expression, and Macrophage Recruitment in a Viral Model of Multiple Sclerosis J. Immunol., March 15, 2000; 164(6): 3207 - 3213. [Abstract] [Full Text] [PDF]

				K. B. Nguyen and C. A. Biron Synergism for Cytokine-Mediated Disease During Concurrent Endotoxin and Viral Challenges: Roles for NK and T Cell IFN-{gamma} Production J. Immunol., May 1, 1999; 162(9): 5238 - 5246. [Abstract] [Full Text] [PDF]

				B. S. Kim, R. L. Yauch, Y. Y. Bahk, J.-A. Kang, M. C. Dal Canto, and C. K. Hall A Spontaneous Low-Pathogenic Variant of Theiler's Virus Contains an Amino Acid Substitution within the Predominant VP1233-250 T-Cell Epitope J. Virol., February 1, 1998; 72(2): 1020 - 1027. [Abstract] [Full Text] [PDF]